Evidence map›Paper›PMID 34430691›Full record

ArticleGynecologic oncology reports2021

Case report:

E A Goulding, P Morreau, M De Silva, M Watson, C van Vliet, B Leung, L J Eva

Abstract readCase Reports
In one paragraph

Article in Gynecologic oncology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Future oncology (London, England) · 2025
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. TPM3::NTRK1-rearranged uterine sarcoma: case report and literature review.International journal of clinical and experimental pathology · 2024
    Article
  8. Article
  9. Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

E A GouldingGynaecological Oncology, National Women's Health, Auckland City Hospital, New Zealand.
P MorreauStarship Children's Hospital, Auckland, New Zealand.
M De SilvaStarship Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand.
M WatsonAuckland City and Starship Children's Hospital, Auckland, New Zealand.
C van VlietPathWest Laboratory Medicine, Perth, Western Australia, Australia.
B LeungRadiology, Starship Children's Hospital, Auckland, New Zealand.
L J EvaGynaecological Oncology, National Women's Health, Auckland City Hospital, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report reviews the case of a 13-year-old patient who presented with a 9 cm

Indexed as

Cervical sarcomaEntrectinibFibrosarcomaNeo-adjuvantNTRK1 fusionTRK inhibitor

Identifiers

PMID34430691
PMCPMC8371228

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.